Navigation Links
Keane 'Optimum' Creates Higher Standards in Healthcare IT, Improved Patient Safety
Date:6/9/2009

Keane Completes Electronic Medical Record (EMR) Implementation for New Jersey-Based Acute Care Facility

BOSTON, June 9 /PRNewswire/ -- Keane, Inc., a global services firm that specializes in optimizing businesses' Information Technology (IT) investments, today announced that it has completed an Electronic Medical Record (EMR) implementation at Capital Health, a two-hospital, 589-bed regional health network, including an ambulatory facility, based in Mercer County, N.J.

Keane's solutions help U.S. healthcare facilities modernize their operations by using technology to prevent medical mistakes, provide better patient care, and implement the most effective treatments, while at the same time achieving cost-saving efficiencies and meaningful returns on health information technology investments. Keane Optimum is especially well suited to help healthcare facilities accelerate the adoption of EMRs in response to the Healthcare IT provisions in the recently approved American Recovery and Reinvestment Act. Specifically, Optimum allows providers to enhance quality, maintain privacy, support clinical decision making and begin to move to a more interoperable environment for improved health care delivery.

As part of its project at Capital Health, Keane installed clinical components of its iMed solution throughout the facility to provide clinicians with immediate access to patient information using a secure, web-enabled technology at the point of service. The facility has rolled out more than 150 computers on wheels (COWs) to assist medical staff at the point of care to ensure accuracy of treatment information.

"Capital Health has a strong commitment to provide our patients with the most state-of-the-art technology supporting the highest standard of care and patient safety," said Gene Grochala, Vice President and CIO of Capital Health. "Keane's iMed product was the most effective solution on the market
'/>"/>

SOURCE Keane, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
2. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
3. Keane Wins Revenue Cycle Management Implementation With Mount Sinai Hospital of Queens
4. Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company
5. A device that measures optimum state of an organ prior to transplanting has been patented
6. Hydra Booster Energizes Ordinary Drinking Water for Better Absorption and Optimum Hydration, Stopping Symptoms of 'Hidden' Dehydration
7. Optimum Lightpath(SM) and GetWellNetwork(R) Transform Hospital Bedside Care with Launch of Interactive Patient Care Service
8. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President
9. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
10. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
11. Prime Access Creates Groundbreaking Ads Targeting Urban Teens for the White Houses National Youth Anti-Drug Media Campaign

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...were treated with cisplatin-based chemotherapy had...side effects and Raynaud-like phenomena, than men ...to a new study published online November 25 in the...arianne Brydy, M.D., of the Department of Oncology..., and colleagues conducted a cross-sectional study...
(Date:11/25/2009)...ollaboration between UCLA engineers and physicians...lion Americans who suffer from peripheral arterial...rteries, peripheral arterial disease, or PAD, is a...ries reduce blood flow to the limbs. The condition...art attack and stroke, and its progression can res...
(Date:11/25/2009)...w definite conclusions, experts say, , ,...ic patients with blocked coronary arteries, there ...r whether patients undergo bypass surgery or angio..., Bypass surgery has been the standard treatmen...se. However, less invasive approaches such as angi...
(Date:11/25/2009)...ent clinics to resume Monday, Nov. 30 , ... -- Centegra Health System is continuing to offer ... Centegra Primary Care (CPC) vaccination clinics s...clinics are at CPC sites in Huntley, Woodstock, Cr...: ,   From 4:30 to 7:30 p.m. Tuesday, ...
(Date:11/25/2009)...s, study finds , , WEDNESDAY, Nov. 25 (...mong the potential problems faced by long-term sur...cisplatin-based chemotherapy, a new study has foun...ated for unilateral testicular cancer between 1980...ucted from 1998 to 2002. , The researchers foun...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...esearchers from the University of Chicago reportin... that nine out of ten doctors believe that it is a...However, only three out of four doctors encourage ...y mentions his or her religious beliefs and experi...
...rectile dysfunction is thought to be a common prob...ing the young, college aged men. But now, Dr. Naja...spital// in Chicago, went a step further in findin...llege-age males in Chicago to throw more light on ...
...espite all the rain, there seems to be enough shin...in cancer malignant melanoma, according to the Env...has embarked on a SunWise Program enabling free ki...tors apply different sunscreen and skin lotions on...
...f breast cancer in women has occurred because of t... seek remedy from a prevalent chemotherapy medicat...ovarian and lung cancers, is getting known for its...mutations are twenty times more receptive to carbo...
...ehavioral problems are more likely to occur in chi...ance abuse, domestic violence and mental health, o...in the Archives of General Psychiatry. // Th...at can contribute to behavior problems in children...
...espite the widespread belief that residents of nur...epartments in hospitals, //it has been found that ...are needs of the residents, even in the presence o...ty of Western Australia and the Royal Perth Hospit...
Other Medicine News:Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 2Health News:Doctors' Response To Patients' Religious Beliefs Can Vary 3Health News:Maternal Difficulties Increase Risk of Behavior Problems in Children 2Health News:Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds 2
(Date:11/25/2009)...e-FirstCall/--ERT(Nasdaq: ERES ),announcedtodaytha...andKeithSchneck,theCompany,sExecutiveVicePresident...ffrayHealthCareConferenceat1:30PMESTonDecember1,20...yaccessthepresentationbyvisitingtheCompany,scorpor...beaccessedat http://www.corporate-ir.net/ireye/con...
(Date:11/25/2009)...swire/--TheFDAgrantedtraditionalapprovalforINTELEN...transcriptaseinhibitor(NNRTI).INTELENCEistheonlyNN...cedadultswhoareexperiencingvirologicfailurewithHIV...ARV)agents.Thetraditionalapprovalisbasedon48-weekd...LENCEiscurrentlymarketedintheU.S.byTibotecTherapeu...
(Date:11/25/2009)...RNewswire/--AMPACFineChemicalsLLC(AFC),asubsidiary...edtodaythatitreceivedtheEnvironmentalResponsibilit...mentalSummit,sponsoredbytheCaliforniaManufacturers...nmentalAssociation(IEA)andtheChemicalIndustryCounc...estigiousawardavailablefromallthreeorganizationsan...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 1Targeting helpers of heat shock proteins could help treat cancer cardiovascular disease 8950 2State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 1State Launches New Campaign to Help Pregnant Smokers Go Tobacco Free 49623 2Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 1Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations 12728 2
...Call/ -- Repligen,Corporation announced today posi...uate the use of RG1068, synthetic human,secretin, ...c duct,structures by magnetic resonance imaging (M...y of detection of structural abnormalities,of the ...in,specificity, consistent with prior data and exp...
...0, 2007--Today, the,New England Journal of Medicin... of Merck,s cervical cancer vaccine, Gardasil,(Qua...8),Recombinant Vaccine). In the first study, Garda...al, vaginal and vulvar diseases,caused by the four..., HPV types 6, 11, 16, and 18. In the second study...
Other Medicine Technology:Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 2Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 3Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 2New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 3New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 5New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 6New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 7New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 8New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 9New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 10New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 11New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 12New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 13New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 14New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 15New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 16New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 17New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 18New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 19New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 20New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 21New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 22New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 23New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 24New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 25New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 26New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 27New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 28New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 29New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 30New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 31New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 32
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: